Product Pathways - MAPK Signaling
SignalSilence® SHP-2 siRNA I #7917
|7917S||300 µl (3 nmol)||---||In Stock||---|
|7917||carrier free and custom formulation / quantity||email request|
Already purchased this product? Write a Review.
Species predicted to react based on 100% sequence homology: Mouse, Monkey.
Western blot analysis of extracts from 293T cells, transfected with 100 nM SignalSilence® Control siRNA (Unconjugated) #6568 (-), SignalSilence® SHP-2 siRNA I (+), or SignalSilence® SHP-2 siRNA II #7927 (+), using SHP-2 (D50F2) Rabbit mAb #3397 (upper) or α-Tubulin (11H10) Rabbit mAb #2125 (lower). The SHP-2 (D50F2) Rabbit mAb confirms silencing of SHP-2 expression, while the α-Tubulin (11H10) Rabbit mAb is used as a loading control.
SignalSilence® SHP-2 siRNA I from Cell Signaling Technology (CST) allows the researcher to specifically inhibit SHP-2 expression using RNA interference, a method whereby gene expression can be selectively silenced through the delivery of double stranded RNA molecules into the cell. All SignalSilence® siRNA products from CST are rigorously tested in-house and have been shown to reduce target protein expression by western analysis.
Oligonucleotide synthesis is monitored base by base through trityl analysis to ensure appropriate coupling efficiency. The oligo is subsequently purified by affinity-solid phase extraction. The annealed RNA duplex is further analyzed by mass spectrometry to verify the exact composition of the duplex. Each lot is compared to the previous lot by mass spectrometry to ensure maximum lot-to-lot consistency.
Directions For Use
CST recommends transfection with 100 nM SignalSilence® SHP-2 siRNA I 48 to 72 hours prior to cell lysis. For transfection procedure, follow protocol provided by the transfection reagent manufacturer. Please feel free to contact CST with any questions on use.
Each vial contains the equivalent of 100 transfections, which corresponds to a final siRNA concentration of 100 nM per transfection in a 24-well plate with a total volume of 300 μl per well.
SHP-2 (PTPN11) is a ubiquitously expressed, nonreceptor protein tyrosine phosphatase (PTP). It participates in signaling events downstream of receptors for growth factors, cytokines, hormones, antigens, and extracellular matrices in the control of cell growth, differentiation, migration, and death (1). Activation of SHP-2 and its association with Gab1 is critical for sustained Erk activation downstream of several growth factor receptors and cytokines (2). In addition to its role in Gab1-mediated Erk activation, SHP-2 attenuates EGF-dependent PI3 kinase activation by dephosphorylating Gab1 at p85 binding sites (3). SHP-2 becomes phosphorylated at Tyr542 and Tyr580 in its carboxy-terminus in response to growth factor receptor activation (4). These phosphorylation events are thought to relieve basal inhibition and stimulate SHP-2 tyrosine phosphatase activity (5). Mutations in the corresponding gene result in a pair of clinically similar disorders (Noonan syndrome and LEOPARD syndrome) that may result from abnormal MAPK regulation (6).
- Qu, C.K. (2000) Cell Res 10, 279-88.
- Maroun, C.R. et al. (2000) Mol Cell Biol 20, 8513-25.
- Zhang, S.Q. et al. (2002) Mol Cell Biol 22, 4062-72.
- Bennett, A.M. et al. (1994) Proc Natl Acad Sci USA 91, 7335-9.
- Lu, W. et al. (2001) Mol Cell 8, 759-69.
- Edouard, T. et al. (2007) Cell Mol Life Sci 64, 1585-90.
Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!
For Research Use Only. Not For Use In Diagnostic Procedures.
SignalSilence® is a trademark of Cell Signaling Technology, Inc.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.